How does TPF improve survival over PF?

Jochen H. Lorch, Olga Goloubeva, Marshall R. Posner

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	421-422
Number of pages	2
Journal	The Lancet Oncology
Volume	12
Issue number	5
DOIs	https://doi.org/10.1016/S1470-2045(11)70110-3
State	Published - May 2011

Access to Document

10.1016/S1470-2045(11)70110-3

Cite this

@article{075fec1597e840e481a4c183af732398,

title = "How does TPF improve survival over PF?",

author = "Lorch, {Jochen H.} and Olga Goloubeva and Posner, {Marshall R.}",

year = "2011",

month = may,

doi = "10.1016/S1470-2045(11)70110-3",

language = "English",

volume = "12",

pages = "421--422",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - How does TPF improve survival over PF?

AU - Lorch, Jochen H.

AU - Goloubeva, Olga

AU - Posner, Marshall R.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79955374235&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(11)70110-3

DO - 10.1016/S1470-2045(11)70110-3

M3 - Letter

AN - SCOPUS:79955374235

SN - 1470-2045

VL - 12

SP - 421

EP - 422

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 5

ER -